They presented the scoring system and concluded that a specific pattern of expression (homogenous + CD34, homogenous + CD10, intermediate or low CD38 and intermediate + CD13) is useful for predicting the BCR::ABL1 in adult BCP-ALL patients [34]. This evidence concerns the gene CD34 and acute lymphoblastic leukemia.